Ultrasound Market - Global Forecast to 2030
商品番号 : SMB-10847
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年1月 |
| ページ数 | 420 |
| 図表数 | 535 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global ultrasound market is projected to reach USD 13.87 billion by 2030 from USD 9.32 billion in 2024, growing at a CAGR of 6.8% during the forecast period.
世界の超音波市場は、2024年の93億2,000万米ドルから2030年までに138億7,000万米ドルに達すると予測されており、予測期間中に6.8%のCAGRで成長します。
The growth of the ultrasound market is driven by various key factors, including increasing prevalence rates of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders. These require sophisticated diagnostic equipment. Increasing demand for early diagnosis and non-invasive options also fuels adoption of the ultrasound technology. Advances in ultrasound itself, including AI integration, 3D/4D imaging, and portable equipment, make it more accessible and versatile in the clinical practice.
“Diagnostic Ultrasound to register largest market share in 2023”
Diagnostic ultrasound accounts for the largest share of the ultrasound market because it is capable of providing real-time, non-invasive imaging for a wide range of medical conditions. Its broad usage in obstetrics, cardiology, musculoskeletal imaging, and emergency care is contributing to its dominance. With this technology, it boasts such high accuracy, very low cost, and ionizing radiation-free; clinicians often turn to this for routine diagnostics. Improved ultrasound technology-3D/4D imaging, for instance, and AI-based tools have improved it so much that the use has remained on the growth track.
“Hospitals segment held the largest share of ultrasound equipment market in 2023, by End-user.”
Hospitals have the largest market share in this ultrasound industry due to its high volume of patients and diversified departments, along with the requirements of advanced imaging diagnostics within a wide spectrum of specializations. Obsterics, cardiology, emergency care, and musculoskeletal imaging are key applications within the hospital setup that have integrated ultrasound technology. The increased cases of chronic diseases and hospital emphasis on earlier diagnosis and treatment create high demand for ultrasound systems. More importantly, the advanced functionalities of ultrasound, such as real-time imaging, non-invasiveness, and increased accuracy, make it of more importance to hospitals, thereby becoming their main consumers of ultrasound technology.
“Asia Pacific to register highest growth rate in the market during the forecast period.”
The Asia-Pacific region is reporting the highest growth rate in the ultrasound market, with factors such as an increasingly prevalent chronic disease population, an aged population, and a widening healthcare infrastructure base. Growth in demand for early and accurate diagnoses coupled with the affordability of ultrasound and its non-invasive nature has further increased adoption across the region. Additionally, growing government efforts to expand the healthcare market, increasing investments in health, diagnostic center expansions, and increase in hospital numbers are leading the rapid growth of this market in the Asia-Pacific region. Technology advancement and the greater availability of portable ultrasound equipment facilitate wider accessibility and adoption in Asia-Pacific.
A number of drivers were responsible for the upswing, including:
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 40%, Tier 30%, and Tier 3 30%
- By Designation: C-level– 55%, Director-level–27%, and Others–18%
- By Region: North America–35%, Europe-32%, Asia Pacific–25%, Latin America-6% , Middle East & Africa-2%
Prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc.(US), Samsung Electronics Co., Ltd (South Korea), Esaote SPA (Italy), Chison Medical Technologies Co., Ltd (China), MobiSante Inc (US), Clarius (Canada), MedGyn Products, Inc (US), Promed Technology (China), Neusoft Corporation (China) among others.
Research Coverage
The ultrasound equipment market has been segmented based on technology, display, component, portability, application, end-user, and region. Key factors for the growth of the market include driving forces, restraints, opportunities, and challenges among the stakeholders. The study also looks into the competition of the leading players within the market. The further division of the market can be seen in micro-markets to gain insight into the growth trends, prospects, and contributions to the overall market. It highlights future revenue growth prospects for various market segments across five major regions.
Key Benefits of Buying the Report:
The report would be useful for new market entrants in the ultrasound market as it gives detailed information about the market. This helps get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. This report segments the market precisely both by end-users and by regions for the purpose of attaining focused insights in the specific market segments. Additionally, it draws out the major trends, challenges, growth drivers, and opportunities to support the strategic decision-making process through adequate analysis.
The report provides the insights on the following pointers:
- Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the ultrasound market. The rise of point-of-care diagnostics and expanding healthcare infrastructure further boosts market growth. Additionally, favorable reimbursement policies and the need for early detection support ultrasound adoption.
- Product Development/Innovation: The report includes emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for ultrasound market.
- Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the ultrasound market.
- Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the ultrasound market.
- Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), among others.
Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.4 YEARS CONSIDERED 35
1.5 CURRENCY CONSIDERED 35
1.6 MARKET STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.1.1 SECONDARY RESEARCH 38
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY RESEARCH 40
2.1.2.1 Key industry insights 41
2.2 MARKET SIZE ESTIMATION 42
2.2.1 BOTTOM-UP APPROACH 44
2.2.1.1 Approach 1: Company revenue estimation approach 44
2.2.1.2 Approach 2: Customer-based market estimation 45
2.2.1.3 Approach 3: Top-down approach 45
2.2.1.4 Approach 4: Primary interviews 46
2.3 DATA TRIANGULATION & MARKET BREAKDOWN 48
2.4 MARKET SHARE ASSESSMENT 49
2.5 STUDY ASSUMPTIONS 49
2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY 50
2.7 LIMITATIONS 50
2.8 RISK ASSESSMENT 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 56
4.1 ULTRASOUND MARKET OVERVIEW 56
4.2 ULTRASOUND MARKET, BY REGION, 2022–2030 57
4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023 58
4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Increasing prevalence of chronic diseases 61
5.2.1.2 Rising patient preference for minimally invasive surgeries 62
5.2.1.3 Rising technological advancements in ultrasound devices 62
5.2.1.4 Growing public and private investments, funding, and grants 63
5.2.2 RESTRAINTS 64
5.2.2.1 Unfavorable reimbursements 64
5.2.2.2 High operating costs 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 Growing applications of therapeutic ultrasound 65
5.2.3.2 Growth in emerging markets 65
5.2.3.3 Development of POC ultrasound devices 66
5.2.4 CHALLENGES 67
5.2.4.1 Growing end-user preference for refurbished equipment 67
5.2.4.2 Shortage of skilled sonographers 67
5.3 INDUSTRY TRENDS 68
5.3.1 ENDOSCOPIC ULTRASOUND 68
5.3.2 WIRELESS AND PORTABLE SYSTEMS 68
5.4 VALUE CHAIN ANALYSIS 69
5.5 SUPPLY CHAIN ANALYSIS 70
5.5.1 PROMINENT COMPANIES 70
5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES 71
5.5.3 END USERS 71
5.6 PORTER’S FIVE FORCES ANALYSIS 72
5.6.1 THREAT OF NEW ENTRANTS 73
5.6.2 BARGAINING POWER OF SUPPLIERS 73
5.6.3 BARGAINING POWER OF BUYERS 73
5.6.4 THREAT OF SUBSTITUTES 73
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.7 KEY STAKEHOLDERS & BUYING CRITERIA 74
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.7.2 BUYING CRITERIA 75
5.8 PATENT ANALYSIS 76
5.9 TRADE DATA ANALYSIS 78
5.9.1 IMPORT DATA 78
5.9.2 EXPORT DATA 79
5.10 KEY CONFERENCES & EVENTS, 2024–2025 79
5.11 UNMET NEEDS AND KEY PAIN POINTS 81
5.12 ECOSYSTEM ANALYSIS 81
5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET 83
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
5.15 TECHNOLOGY ANALYSIS 85
5.15.1 KEY TECHNOLOGIES 85
5.15.1.1 Contrast-enhanced ultrasound (CEUS) 85
5.15.1.2 Portable and handheld ultrasound devices 86
5.15.2 COMPLEMENTARY TECHNOLOGIES 86
5.15.2.1 Elastography 86
5.15.2.2 Fluoroscopy 86
5.15.3 ADJACENT TECHNOLOGIES 86
5.15.3.1 PET/CT 86
5.16 CASE STUDY ANALYSIS 87
5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS 87
5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY 87
5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE 88
5.17 REGULATORY ANALYSIS 88
5.17.1 NORTH AMERICA 88
5.17.1.1 US 88
5.17.1.2 Canada 90
5.17.2 EUROPE 90
5.17.3 ASIA PACIFIC 91
5.17.3.1 Japan 91
5.17.3.2 China 92
5.17.3.3 India 93
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.18 INVESTMENT & FUNDING SCENARIO 96
5.19 PRICING ANALYSIS 97
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION 97
5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER 101
5.20 REIMBURSEMENT SCENARIO 102
6 ULTRASOUND MARKET, BY TECHNOLOGY 103
6.1 INTRODUCTION 104
6.2 DIAGNOSTIC ULTRASOUND 104
6.2.1 2D ULTRASOUND 108
6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound 108
6.2.2 3D & 4D ULTRASOUND 111
6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth 111
6.2.3 DOPPLER ULTRASOUND 114
6.2.3.1 Growing applications in cardiology and vascular to drive market growth 114
6.2.4 CONTRAST-ENHANCED ULTRASOUND 117
6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems
to boost demand 117
6.3 THERAPEUTIC ULTRASOUND 120
6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND 124
6.3.1.1 Advancing cancer treatment with HIFU to fuel growth 124
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY 128
6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques
and technologies to propel market 128
7 ULTRASOUND MARKET, BY DISPLAY 132
7.1 INTRODUCTION 133
7.2 COLOR ULTRASOUND 134
7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH 134
7.3 BLACK & WHITE ULTRASOUND 137
7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND 137
8 ULTRASOUND MARKET, BY PORTABILITY 142
8.1 INTRODUCTION 143
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS 144
8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND
SYSTEMS TO DRIVE MARKET GROWTH 144
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS 148
8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH 148
8.4 POC ULTRASOUND DEVICES 152
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
FOR POC ULTRASOUND DEVICES 152
9 ULTRASOUND MARKET, BY APPLICATION 156
9.1 INTRODUCTION 157
9.2 RADIOLOGY/GENERAL IMAGING 157
9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED
USE OF THIS APPLICATION 157
9.3 CARDIOLOGY 160
9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH 160
9.4 OB/GYN 163
9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET 163
9.5 UROLOGY 167
9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET 167
9.6 VASCULAR 170
9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 170
9.7 ORTHOPEDIC & MUSCULOSKELETAL 174
9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH 174
9.8 PAIN MANAGEMENT 177
9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH 177
9.9 PEDIATRIC 180
9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL
MORTALITY TO SPUR GROWTH 180
9.10 OTHER APPLICATIONS 184
10 ULTRASOUND MARKET, BY COMPONENT 188
10.1 INTRODUCTION 189
10.2 TRANSDUCERS/PROBES 190
10.2.1 CURVILINEAR/CONVEX ARRAY PROBES 194
10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound
probes to boost market 194
10.2.2 LINEAR ARRAY PROBES 195
10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand 195
10.2.3 PHASED ARRAY PROBES 196
10.2.3.1 Advanced imaging capabilities to drive market growth 196
10.2.4 OTHER PROBES 197
10.3 WORKSTATIONS 197
10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND
FOR WORKSTATIONS 197
10.4 OTHER COMPONENTS 201
11 ULTRASOUND MARKET, BY END USER 204
11.1 INTRODUCTION 205
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS 205
11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH 205
11.3 MATERNITY CENTERS 207
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS
FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH 207
11.4 AMBULATORY CENTERS 208
11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH 208
11.5 RESEARCH & ACADEMIC INSTITUTES 209
11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH 209
11.6 OTHER END USERS 210
12 ULTRASOUND MARKET, BY REGION 212
12.1 INTRODUCTION 213
12.2 EUROPE 214
12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 214
12.2.2 GERMANY 220
12.2.2.1 Growing healthcare expenditures and grants to drive market 220
12.2.3 FRANCE 224
12.2.3.1 Increasing population and rising number of centers to drive market 224
12.2.4 UK 227
12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth 227
12.2.5 ITALY 231
12.2.5.1 Increased availability of reimbursement coverage for diagnostic
procedures to drive market 231
12.2.6 SPAIN 234
12.2.6.1 Growing focus on cancer research to support market growth 234
12.2.7 REST OF EUROPE 238
12.3 NORTH AMERICA 241
12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 241
12.3.2 US 246
12.3.2.1 Rise in cancer prevalence to drive market 246
12.3.3 CANADA 254
12.3.3.1 New product launches & conferences to drive market 254
12.4 ASIA PACIFIC 258
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 258
12.4.2 CHINA 264
12.4.2.1 Increasing acquisitions and partnerships to drive market 264
12.4.3 JAPAN 268
12.4.3.1 Established healthcare infrastructure and research facilities
to drive market 268
12.4.4 INDIA 272
12.4.4.1 Government initiatives to drive market 272
12.4.5 AUSTRALIA 275
12.4.5.1 Growing healthcare spending and increasing investments in research
to drive market 275
12.4.6 SOUTH KOREA 279
12.4.6.1 Well-developed healthcare system and conferences to drive market 279
12.4.7 REST OF ASIA PACIFIC 283
12.5 LATIN AMERICA 287
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 287
12.5.2 BRAZIL 292
12.5.2.1 Greater purchasing power and favorable demographic conditions
to drive market 292
12.5.3 MEXICO 295
12.5.3.1 Increased medical tourism and better government healthcare
initiatives to drive market 295
12.5.4 REST OF LATIN AMERICA 298
12.6 MIDDLE EAST & AFRICA 302
12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET 302
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302
12.6.3 GCC COUNTRIES 307
12.6.3.1 Developments in investment approach to drive market 307
12.6.4 REST OF MIDDLE EAST & AFRICA 310
13 COMPETITIVE LANDSCAPE 314
13.1 INTRODUCTION 314
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 314
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET 315
13.3 REVENUE ANALYSIS, 2019–2023 316
13.4 MARKET SHARE ANALYSIS, 2023 317
13.4.1 RANKING OF KEY MARKET PLAYERS 319
13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023 319
13.5.1 STARS 319
13.5.2 EMERGING LEADERS 319
13.5.3 PERVASIVE PLAYERS 319
13.5.4 PARTICIPANTS 320
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 321
13.5.5.1 Company footprint 321
13.5.5.2 Region footprint 322
13.5.5.3 Technology footprint 323
13.5.5.4 Display footprint 324
13.5.5.5 Portability footprint 325
13.5.5.6 Component footprint 326
13.5.5.7 Application footprint 327
13.5.5.8 End-user footprint 328
13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET
(STARTUPS/SMES), 2023 329
13.6.1 PROGRESSIVE COMPANIES 329
13.6.2 RESPONSIVE COMPANIES 329
13.6.3 DYNAMIC COMPANIES 329
13.6.4 STARTING BLOCKS 329
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 331
13.7 COMPANY VALUATION & FINANCIAL METRICS 332
13.7.1 FINANCIAL METRICS 332
13.7.2 COMPANY VALUATION 332
13.8 BRAND/PRODUCT COMPARISON 333
13.9 COMPETITIVE SCENARIO 334
13.9.1 PRODUCT LAUNCHES & APPROVALS 334
13.9.2 DEALS 335
14 COMPANY PROFILES 336
14.1 KEY PLAYERS 336
14.1.1 GE HEALTHCARE 336
14.1.1.1 Business overview 336
14.1.1.2 Products offered 337
14.1.1.3 Recent developments 339
14.1.1.3.1 Product launches, approvals, and upgrades 339
14.1.1.3.2 Deals 341
14.1.1.3.3 Other developments 342
14.1.1.4 MnM view 342
14.1.1.4.1 Right to win 342
14.1.1.4.2 Strategic choices 342
14.1.1.4.3 Weaknesses & competitive threats 342
14.1.2 PHILIPS HEALTHCARE 343
14.1.2.1 Business overview 343
14.1.2.2 Products offered 344
14.1.2.3 Recent developments 346
14.1.2.3.1 Product launches & approvals 346
14.1.2.3.2 Deals 346
14.1.2.4 MnM view 347
14.1.2.4.1 Right to win 347
14.1.2.4.2 Strategic choices 347
14.1.2.4.3 Weaknesses & competitive threats 347
14.1.3 CANON MEDICAL SYSTEMS CORPORATION 348
14.1.3.1 Business overview 348
14.1.3.2 Products offered 350
14.1.3.3 Recent developments 351
14.1.3.3.1 Product launches 351
14.1.3.3.2 Deals 351
14.1.3.3.3 Expansions 351
14.1.3.4 MnM view 352
14.1.3.4.1 Right to win 352
14.1.3.4.2 Strategic choices 352
14.1.3.4.3 Weaknesses & competitive threats 352
14.1.4 SIEMENS HEALTHINEERS AG 353
14.1.4.1 Business overview 353
14.1.4.2 Products offered 355
14.1.4.3 Recent developments 355
14.1.4.3.1 Product launches 355
14.1.4.3.2 Deals 356
14.1.4.3.3 Expansions 356
14.1.4.4 MnM view 356
14.1.4.4.1 Right to win 356
14.1.4.4.2 Strategic choices 356
14.1.4.4.3 Weaknesses & competitive threats 357
14.1.5 FUJIFILM CORPORATION 358
14.1.5.1 Business overview 358
14.1.5.2 Products offered 359
14.1.5.3 Recent developments 361
14.1.5.3.1 Product launches 361
14.1.5.3.2 Deals 361
14.1.5.3.3 Expansions 362
14.1.5.4 MnM view 362
14.1.5.4.1 Right to win 362
14.1.5.4.2 Strategic choices 362
14.1.5.4.3 Weaknesses & competitive threats 362
14.1.6 HOLOGIC, INC. 363
14.1.6.1 Business overview 363
14.1.6.2 Products offered 365
14.1.6.3 Recent developments 366
14.1.6.3.1 Product launches 366
14.1.6.3.2 Deals 367
14.1.6.3.3 Expansions 367
14.1.7 SAMSUNG ELECTRONICS CO., LTD. 368
14.1.7.1 Business overview 368
14.1.7.2 Products offered 369
14.1.7.3 Recent developments 371
14.1.7.3.1 Product launches 371
14.1.7.3.2 Deals 372
14.1.7.3.3 Other developments 372
14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED 373
14.1.8.1 Business overview 373
14.1.8.2 Products offered 374
14.1.8.3 Recent developments 376
14.1.8.3.1 Product launches 376
14.1.8.3.2 Deals 377
14.1.9 ESAOTE SPA 378
14.1.9.1 Business overview 378
14.1.9.2 Products offered 379
14.1.9.3 Recent developments 381
14.1.9.3.1 Product launches 381
14.1.9.3.2 Deals 381
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD. 382
14.1.10.1 Business overview 382
14.1.10.2 Products offered 383
14.1.10.3 Recent developments 384
14.1.10.3.1 Product launches 384
14.1.10.3.2 Deals 384
14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD. 385
14.1.11.1 Business overview 385
14.1.11.2 Products offered 386
14.1.11.3 Recent developments 387
14.1.11.3.1 Product launches 387
14.1.12 KONICA MINOLTA, INC 388
14.1.12.1 Business overview 388
14.1.12.2 Products offered 389
14.1.13 CLARIUS 390
14.1.13.1 Business overview 390
14.1.13.2 Products offered 390
14.1.13.3 Recent developments 391
14.1.13.3.1 Product launches 391
14.1.13.3.2 Deals 392
14.1.14 MEDGYN PRODUCTS, INC. 393
14.1.14.1 Business overview 393
14.1.14.2 Products offered 393
14.1.15 PROMED TECHNOLOGY CO., LTD. 394
14.1.15.1 Business overview 394
14.1.15.2 Products offered 394
14.2 OTHER COMPANIES 396
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC. 396
14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD. 397
14.2.3 YOUKEY MEDICAL 398
14.2.4 SIUI 399
14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING 400
14.2.6 BUTTERFLY NETWORK, INC. 401
14.2.7 ALPINION MEDICAL SYSTEMS 402
14.2.8 EDAN INSTRUMENTS, INC. 403
14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD. 404
14.2.10 ECHONOUS INC. 405
14.2.11 MOBISANTE, INC. 406
14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD. 407
14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD. 408
14.2.14 SONOSCAPE MEDICAL CORP. 408
14.2.15 CURA HEALTHCARE 410
15 APPENDIX 411
15.1 DISCUSSION GUIDE 411
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 416
15.3 CUSTOMIZATION OPTIONS 418
15.4 RELATED REPORTS 418
15.5 AUTHOR DETAILS 419
LIST OF TABLES
TABLE 1 ULTRASOUND MARKET: INCLUSIONS & EXCLUSIONS 34
TABLE 2 LIMITATIONS AND ASSOCIATED RISKS 50
TABLE 3 RECENT PRODUCT LAUNCHES IN ULTRASOUND MARKET 63
TABLE 4 COMPARISON BETWEEN AVERAGE SELLING PRICE OF ULTRASOUND
AND REFURBISHED MEDICAL EQUIPMENT 67
TABLE 5 ULTRASOUND MARKET: IMPACT OF PORTER’S FIVE FORCES 72
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 74
TABLE 7 KEY BUYING CRITERIA, BY END USER 75
TABLE 8 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024 77
TABLE 9 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 78
TABLE 10 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2023 (USD THOUSAND) 79
TABLE 11 ULTRASOUND MARKET: KEY CONFERENCES & EVENTS, 2024–2025 79
TABLE 12 ULTRASOUND MARKET: CURRENT UNMET NEEDS 81
TABLE 13 ULTRASOUND MARKET: ROLE OF COMPANIES IN ECOSYSTEM 82
TABLE 14 US FDA: MEDICAL DEVICE CLASSIFICATION 89
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 89
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 91
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 92
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 24 AVERAGE SELLING PRICE OF ULTRASOUND, BY REGION, 2021–2023 (USD THOUSAND) 99
TABLE 25 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD) 101
TABLE 26 US: MAJOR CPT CODES FOR ULTRASOUND, 2023 102
TABLE 27 ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 104
TABLE 28 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 105
TABLE 29 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 105
TABLE 30 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 106
TABLE 31 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 106
TABLE 32 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 107
TABLE 33 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 107
TABLE 34 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 108
TABLE 35 2D ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 109
TABLE 36 NORTH AMERICA: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109
TABLE 37 EUROPE: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 110
TABLE 38 ASIA PACIFIC: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 110
TABLE 39 LATIN AMERICA: 2D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111
TABLE 40 MIDDLE EAST & AFRICA: 2D ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 111
TABLE 41 3D & 4D ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 112
TABLE 42 NORTH AMERICA: 3D & 4D ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 112
TABLE 43 EUROPE: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 44 ASIA PACIFIC: 3D & 4D ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 45 LATIN AMERICA: 3D & 4D ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 46 MIDDLE EAST & AFRICA: 3D & 4D ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 47 DOPPLER ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 115
TABLE 48 NORTH AMERICA: DOPPLER ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 49 EUROPE: DOPPLER ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 50 ASIA PACIFIC: DOPPLER ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 51 LATIN AMERICA: DOPPLER ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 52 MIDDLE EAST & AFRICA: DOPPLER ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 53 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 118
TABLE 54 NORTH AMERICA: CONTRAST-ENHANCED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 118
TABLE 55 EUROPE: CONTRAST-ENHANCED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 56 ASIA PACIFIC: CONTRAST-ENHANCED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 57 LATIN AMERICA: CONTRAST-ENHANCED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 58 MIDDLE EAST & AFRICA: CONTRAST-ENHANCED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 59 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 121
TABLE 60 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 121
TABLE 61 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 62 EUROPE: THERAPEUTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 63 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 64 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 65 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 124
TABLE 66 HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY REGION, 2022–2030 (USD MILLION) 125
TABLE 67 NORTH AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 68 EUROPE: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 126
TABLE 69 ASIA PACIFIC: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 126
TABLE 70 LATIN AMERICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 127
TABLE 71 MIDDLE EAST & AFRICA: HIGH-INTENSITY-FOCUSED ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 127
TABLE 72 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY REGION, 2022–2030 (USD MILLION) 128
TABLE 73 NORTH AMERICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 74 EUROPE: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 75 ASIA PACIFIC: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 130
TABLE 76 LATIN AMERICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 130
TABLE 77 MIDDLE EAST & AFRICA: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 131
TABLE 78 ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 133
TABLE 79 ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (UNITS) 133
TABLE 80 COLOR ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 134
TABLE 81 COLOR ULTRASOUND MARKET, BY REGION, 2022–2030 (UNITS) 135
TABLE 82 NORTH AMERICA: COLOR ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 135
TABLE 83 EUROPE: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 136
TABLE 84 ASIA PACIFIC: COLOR ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 136
TABLE 85 LATIN AMERICA: COLOR ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 137
TABLE 86 MIDDLE EAST & AFRICA: COLOR ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 137
TABLE 87 BLACK & WHITE ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 138
TABLE 88 BLACK & WHITE ULTRASOUND MARKET, BY REGION, 2022–2030 (UNITS) 138
TABLE 89 NORTH AMERICA: BLACK & WHITE ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 90 EUROPE: BLACK & WHITE ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 91 ASIA PACIFIC: BLACK & WHITE ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 140
TABLE 92 LATIN AMERICA: BLACK & WHITE ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 140
TABLE 93 MIDDLE EAST & AFRICA: BLACK & WHITE ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 141
TABLE 94 ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 143
TABLE 95 ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (UNITS) 143
TABLE 96 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY REGION, 2022–2030 (USD MILLION) 144
TABLE 97 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY REGION, 2022–2030 (UNITS) 145
TABLE 98 NORTH AMERICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 145
TABLE 99 EUROPE: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 146
TABLE 100 ASIA PACIFIC: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 146
TABLE 101 LATIN AMERICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 147
TABLE 102 MIDDLE EAST & AFRICA: TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 147
TABLE 103 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY REGION, 2022–2030 (USD MILLION) 148
TABLE 104 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY REGION, 2022–2030 (UNITS) 149
TABLE 105 NORTH AMERICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 149
TABLE 106 EUROPE: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 150
TABLE 107 ASIA PACIFIC: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 150
TABLE 108 LATIN AMERICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 151
TABLE 109 MIDDLE EAST & AFRICA: COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 151
TABLE 110 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 152
TABLE 111 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2030 (UNITS) 153
TABLE 112 NORTH AMERICA: POC ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 153
TABLE 113 EUROPE: POC ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 154
TABLE 114 ASIA PACIFIC: POC ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 154
TABLE 115 LATIN AMERICA: POC ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 155
TABLE 116 MIDDLE EAST & AFRICA: POC ULTRASOUND SYSTEMS MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 155
TABLE 117 ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 157
TABLE 118 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 158
TABLE 119 NORTH AMERICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 158
TABLE 120 EUROPE: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 159
TABLE 121 ASIA PACIFIC: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 159
TABLE 122 LATIN AMERICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 160
TABLE 123 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 160
TABLE 124 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 161
TABLE 125 NORTH AMERICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 161
TABLE 126 EUROPE: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 162
TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 162
TABLE 128 LATIN AMERICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 163
TABLE 129 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 163
TABLE 130 ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 164
TABLE 131 NORTH AMERICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 165
TABLE 132 EUROPE: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 165
TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 166
TABLE 134 LATIN AMERICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 166
TABLE 135 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OB/GYN APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 167
TABLE 136 ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 168
TABLE 137 NORTH AMERICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 168
TABLE 138 EUROPE: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 169
TABLE 139 ASIA PACIFIC: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 169
TABLE 140 LATIN AMERICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 170
TABLE 141 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR UROLOGY APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 170
TABLE 142 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 171
TABLE 143 NORTH AMERICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 171
TABLE 144 EUROPE: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 172
TABLE 145 ASIA PACIFIC: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 172
TABLE 146 LATIN AMERICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 173
TABLE 147 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR VASCULAR APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 173
TABLE 148 ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 174
TABLE 149 NORTH AMERICA: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 175
TABLE 150 EUROPE: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL
APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 175
TABLE 151 ASIA PACIFIC: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 176
TABLE 152 LATIN AMERICA: ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 176
TABLE 153 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR ORTHOPEDIC &
MUSCULOSKELETAL APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 177
TABLE 154 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 178
TABLE 155 NORTH AMERICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 178
TABLE 156 EUROPE: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 179
TABLE 157 ASIA PACIFIC: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 179
TABLE 158 LATIN AMERICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 180
TABLE 159 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR PAIN MANAGEMENT
APPLICATIONS, BY COUNTRY, 2022–2030 (USD MILLION) 180
TABLE 160 GLOBAL MORTALITY RATE OF NEONATES, CHILDREN, AND ADOLESCENTS IN 2022 181
TABLE 161 ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 181
TABLE 162 NORTH AMERICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 182
TABLE 163 EUROPE: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 182
TABLE 164 ASIA PACIFIC: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 183
TABLE 165 LATIN AMERICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 183
TABLE 166 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR PEDIATRIC APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 184
TABLE 167 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2030 (USD MILLION) 184
TABLE 168 NORTH AMERICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 185
TABLE 169 EUROPE: ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 185
TABLE 170 ASIA PACIFIC: ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 186
TABLE 171 LATIN AMERICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 186
TABLE 172 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 187
TABLE 173 ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 189
TABLE 174 ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2022–2030 (USD MILLION) 190
TABLE 175 ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY REGION, 2022–2030 (USD MILLION) 191
TABLE 176 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY COUNTRY, 2022–2030 (USD MILLION) 191
TABLE 177 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY COUNTRY, 2022–2030 (USD MILLION) 192
TABLE 178 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY COUNTRY, 2022–2030 (USD MILLION) 192
TABLE 179 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY COUNTRY, 2022–2030 (USD MILLION) 193
TABLE 180 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY COUNTRY, 2022–2030 (USD MILLION) 193
TABLE 181 ULTRASOUND MARKET FOR CURVILINEAR/CONVEX ARRAY PROBES,
BY REGION, 2022–2030 (USD MILLION) 194
TABLE 182 ULTRASOUND MARKET FOR LINEAR ARRAY PROBES,
BY REGION, 2022–2030 (USD MILLION) 195
TABLE 183 ULTRASOUND MARKET FOR PHASED ARRAY PROBES,
BY REGION, 2022–2030 (USD MILLION) 196
TABLE 184 ULTRASOUND MARKET FOR OTHER PROBES, BY REGION, 2022–2030 (USD MILLION) 197
TABLE 185 ULTRASOUND MARKET FOR WORKSTATIONS, BY REGION, 2022–2030 (USD MILLION) 198
TABLE 186 NORTH AMERICA: ULTRASOUND MARKET FOR WORKSTATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 198
TABLE 187 EUROPE: ULTRASOUND MARKET FOR WORKSTATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 199
TABLE 188 ASIA PACIFIC: ULTRASOUND MARKET FOR WORKSTATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 199
TABLE 189 LATIN AMERICA: ULTRASOUND MARKET FOR WORKSTATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 200
TABLE 190 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR WORKSTATIONS,
BY COUNTRY, 2022–2030 (USD MILLION) 200
TABLE 191 ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY REGION, 2022–2030 (USD MILLION) 201
TABLE 192 NORTH AMERICA: ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 201
TABLE 193 EUROPE: ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 202
TABLE 194 ASIA PACIFIC: ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 202
TABLE 195 LATIN AMERICA: ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 203
TABLE 196 MIDDLE EAST & AFRICA: ULTRASOUND MARKET FOR OTHER COMPONENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 203
TABLE 197 ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 205
TABLE 198 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS,
AND DIAGNOSTIC CENTERS, BY REGION, 2022–2030 (USD MILLION) 206
TABLE 199 ULTRASOUND MARKET FOR MATERNITY CENTERS,
BY REGION, 2022–2030 (USD MILLION) 207
TABLE 200 ULTRASOUND MARKET FOR AMBULATORY CENTERS,
BY REGION, 2022–2030 (USD MILLION) 209
TABLE 201 ULTRASOUND MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2022–2030 (USD MILLION) 210
TABLE 202 ULTRASOUND MARKET FOR OTHER END USERS,
BY REGION, 2022–2030 (USD MILLION) 211
TABLE 203 ULTRASOUND MARKET, BY REGION, 2022–2030 (USD MILLION) 213
TABLE 204 EUROPE: MACROECONOMIC OUTLOOK 214
TABLE 205 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 216
TABLE 206 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 216
TABLE 207 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 217
TABLE 208 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 217
TABLE 209 EUROPE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 217
TABLE 210 EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 218
TABLE 211 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 218
TABLE 212 EUROPE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 219
TABLE 213 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2022–2030 (USD MILLION) 219
TABLE 214 EUROPE: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 220
TABLE 215 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 221
TABLE 216 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 221
TABLE 217 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 222
TABLE 218 GERMANY: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 222
TABLE 219 GERMANY: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 222
TABLE 220 GERMANY: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 223
TABLE 221 GERMANY: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 223
TABLE 222 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 224
TABLE 223 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 225
TABLE 224 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 225
TABLE 225 FRANCE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 225
TABLE 226 FRANCE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 226
TABLE 227 FRANCE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 226
TABLE 228 FRANCE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 227
TABLE 229 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 228
TABLE 230 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 228
TABLE 231 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 228
TABLE 232 UK: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 229
TABLE 233 UK: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 229
TABLE 234 UK: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 230
TABLE 235 UK: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 230
TABLE 236 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 231
TABLE 237 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 232
TABLE 238 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 232
TABLE 239 ITALY: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 232
TABLE 240 ITALY: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 233
TABLE 241 ITALY: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 233
TABLE 242 ITALY: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 234
TABLE 243 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 235
TABLE 244 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 235
TABLE 245 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 236
TABLE 246 SPAIN: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 236
TABLE 247 SPAIN: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 236
TABLE 248 SPAIN: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 237
TABLE 249 SPAIN: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 237
TABLE 250 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 238
TABLE 251 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 239
TABLE 252 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 239
TABLE 253 REST OF EUROPE: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 239
TABLE 254 REST OF EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 240
TABLE 255 REST OF EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 240
TABLE 256 REST OF EUROPE: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 241
TABLE 257 NORTH AMERICA: MACROECONOMIC OUTLOOK 242
TABLE 258 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 242
TABLE 259 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 242
TABLE 260 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 243
TABLE 261 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 243
TABLE 262 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 243
TABLE 263 NORTH AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 244
TABLE 264 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 244
TABLE 265 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 245
TABLE 266 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2022–2030 (USD MILLION) 245
TABLE 267 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 246
TABLE 268 POCUS ULTRASOUND CPT CODES (2021) 247
TABLE 269 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 251
TABLE 270 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 251
TABLE 271 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 252
TABLE 272 US: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 252
TABLE 273 US: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 252
TABLE 274 US: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 253
TABLE 275 US: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 253
TABLE 276 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 255
TABLE 277 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 255
TABLE 278 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 255
TABLE 279 CANADA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 256
TABLE 280 CANADA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 256
TABLE 281 CANADA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 257
TABLE 282 CANADA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 257
TABLE 283 ASIA PACIFIC: MACROECONOMIC INDICATORS 258
TABLE 284 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 260
TABLE 285 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 260
TABLE 286 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 261
TABLE 287 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 261
TABLE 288 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 261
TABLE 289 ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 262
TABLE 290 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 262
TABLE 291 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 263
TABLE 292 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2022–2030 (USD MILLION) 263
TABLE 293 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 264
TABLE 294 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 265
TABLE 295 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 265
TABLE 296 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 266
TABLE 297 CHINA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 266
TABLE 298 CHINA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 266
TABLE 299 CHINA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 267
TABLE 300 CHINA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 267
TABLE 301 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 269
TABLE 302 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 269
TABLE 303 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 269
TABLE 304 JAPAN: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 270
TABLE 305 JAPAN: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 270
TABLE 306 JAPAN: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 271
TABLE 307 JAPAN: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 271
TABLE 308 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 272
TABLE 309 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 273
TABLE 310 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 273
TABLE 311 INDIA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 273
TABLE 312 INDIA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 274
TABLE 313 INDIA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 274
TABLE 314 INDIA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 275
TABLE 315 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 276
TABLE 316 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 276
TABLE 317 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 276
TABLE 318 AUSTRALIA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 277
TABLE 319 AUSTRALIA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 277
TABLE 320 AUSTRALIA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 278
TABLE 321 AUSTRALIA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 278
TABLE 322 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 280
TABLE 323 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 280
TABLE 324 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 280
TABLE 325 SOUTH KOREA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 281
TABLE 326 SOUTH KOREA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 281
TABLE 327 SOUTH KOREA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 282
TABLE 328 SOUTH KOREA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 282
TABLE 329 REST OF ASIA PACIFIC: ULTRASOUND MARKET,
BY TECHNOLOGY, 2022–2030 (USD MILLION) 283
TABLE 330 REST OF ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 331 REST OF ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 332 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 285
TABLE 333 REST OF ASIA PACIFIC: ULTRASOUND MARKET,
BY PORTABILITY, 2022–2030 (USD MILLION) 285
TABLE 334 REST OF ASIA PACIFIC: ULTRASOUND MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 286
TABLE 335 REST OF ASIA PACIFIC: ULTRASOUND MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 286
TABLE 336 LATIN AMERICA: MACROECONOMIC OUTLOOK 287
TABLE 337 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 288
TABLE 338 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 288
TABLE 339 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 288
TABLE 340 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 289
TABLE 341 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 289
TABLE 342 LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 289
TABLE 343 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 290
TABLE 344 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 290
TABLE 345 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES,
BY TYPE, 2022–2030 (USD MILLION) 291
TABLE 346 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2022–2030 (USD MILLION) 291
TABLE 347 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 292
TABLE 348 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 292
TABLE 349 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 293
TABLE 350 BRAZIL: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 293
TABLE 351 BRAZIL: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 293
TABLE 352 BRAZIL: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 294
TABLE 353 BRAZIL: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 294
TABLE 354 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 295
TABLE 355 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 296
TABLE 356 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2022–2030 (USD MILLION) 296
TABLE 357 MEXICO: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 296
TABLE 358 MEXICO: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 297
TABLE 359 MEXICO: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 297
TABLE 360 MEXICO: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 298
TABLE 361 REST OF LATIN AMERICA: ULTRASOUND MARKET,
BY TECHNOLOGY, 2022–2030 (USD MILLION) 298
TABLE 362 REST OF LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 363 REST OF LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 364 REST OF LATIN AMERICA: ULTRASOUND MARKET,
BY DISPLAY, 2022–2030 (USD MILLION) 300
TABLE 365 REST OF LATIN AMERICA: ULTRASOUND MARKET,
BY PORTABILITY, 2022–2030 (USD MILLION) 300
TABLE 366 REST OF LATIN AMERICA: ULTRASOUND MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 301
TABLE 367 REST OF LATIN AMERICA: ULTRASOUND MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 301
TABLE 368 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 302
TABLE 369 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 303
TABLE 370 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY TECHNOLOGY, 2022–2030 (USD MILLION) 303
TABLE 371 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 303
TABLE 372 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 304
TABLE 373 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY DISPLAY, 2022–2030 (USD MILLION) 304
TABLE 374 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY PORTABILITY, 2022–2030 (USD MILLION) 304
TABLE 375 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 305
TABLE 376 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 305
TABLE 377 MIDDLE EAST & AFRICA: TRANSDUCERS/PROBES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 306
TABLE 378 MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY END USER, 2022–2030 (USD MILLION) 306
TABLE 379 GCC COUNTRIES: ULTRASOUND MARKET, BY TECHNOLOGY, 2022–2030 (USD MILLION) 307
TABLE 380 GCC COUNTRIES: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 307
TABLE 381 GCC COUNTRIES: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 308
TABLE 382 GCC COUNTRIES: ULTRASOUND MARKET, BY DISPLAY, 2022–2030 (USD MILLION) 308
TABLE 383 GCC COUNTRIES: ULTRASOUND MARKET, BY PORTABILITY, 2022–2030 (USD MILLION) 308
TABLE 384 GCC COUNTRIES: ULTRASOUND MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 309
TABLE 385 GCC COUNTRIES: ULTRASOUND MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 309
TABLE 386 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY TECHNOLOGY, 2022–2030 (USD MILLION) 310
TABLE 387 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 310
TABLE 388 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET,
BY TYPE, 2022–2030 (USD MILLION) 311
TABLE 389 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY DISPLAY, 2022–2030 (USD MILLION) 311
TABLE 390 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY PORTABILITY, 2022–2030 (USD MILLION) 312
TABLE 391 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 312
TABLE 392 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 313
TABLE 393 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN ULTRASOUND MARKET 315
TABLE 394 ULTRASOUND MARKET: DEGREE OF COMPETITION 318
TABLE 395 ULTRASOUND MARKET: REGION FOOTPRINT 322
TABLE 396 ULTRASOUND MARKET: TECHNOLOGY FOOTPRINT 323
TABLE 397 ULTRASOUND MARKET: DISPLAY FOOTPRINT 324
TABLE 398 ULTRASOUND MARKET: PORTABILITY FOOTPRINT 325
TABLE 399 ULTRASOUND MARKET: COMPONENT FOOTPRINT 326
TABLE 400 ULTRASOUND MARKET: APPLICATION FOOTPRINT 327
TABLE 401 ULTRASOUND MARKET: END-USER FOOTPRINT 328
TABLE 402 ULTRASOUND EQUIPMENT MARKET: COMPETITIVE BENCHMARKING
OF KEY EMERGING PLAYERS/STARTUPS 331
TABLE 403 ULTRASOUND MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–NOVEMBER 2024 334
TABLE 404 ULTRASOUND MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 335
TABLE 405 GE HEALTHCARE: COMPANY OVERVIEW 336
TABLE 406 GE HEALTHCARE: PRODUCTS OFFERED 337
TABLE 407 GE HEALTHCARE: PRODUCT LAUNCHES, APPROVALS, AND UPGRADES,
JANUARY 2021–NOVEMBER 2024 339
TABLE 408 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 341
TABLE 409 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 342
TABLE 410 PHILIPS HEALTHCARE: COMPANY OVERVIEW 343
TABLE 411 PHILIPS HEALTHCARE: PRODUCTS OFFERED 344
TABLE 412 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–NOVEMBER 2024 346
TABLE 413 PHILIPS HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 346
TABLE 414 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 348
TABLE 415 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 350
TABLE 416 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 351
TABLE 417 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 351
TABLE 418 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,
JANUARY 2021–NOVEMBER 2024 351
TABLE 419 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 353
TABLE 420 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 355
TABLE 421 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 355
TABLE 422 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024 356
TABLE 423 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 356
TABLE 424 FUJIFILM CORPORATION: COMPANY OVERVIEW 358
TABLE 425 FUJIFILM CORPORATION: PRODUCTS OFFERED 359
TABLE 426 FUJIFILM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 361
TABLE 427 FUJIFILM CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 361
TABLE 428 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 362
TABLE 429 HOLOGIC, INC.: COMPANY OVERVIEW 363
TABLE 430 HOLOGIC, INC.: PRODUCTS OFFERED 365
TABLE 431 HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 366
TABLE 432 HOLOGIC, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 367
TABLE 433 HOLOGIC, INC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 367
TABLE 434 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW 368
TABLE 435 SAMSUNG ELECTRONICS CO., LTD.: PRODUCTS OFFERED 369
TABLE 436 SAMSUNG ELECTRONICS CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 371
TABLE 437 SAMSUNG ELECTRONICS CO., LTD.: DEALS, JANUARY 2021–MARCH 2024 372
TABLE 438 SAMSUNG ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS,
JANUARY 2021–MARCH 2024 372
TABLE 439 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY OVERVIEW 373
TABLE 440 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCTS OFFERED 374
TABLE 441 MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 376
TABLE 442 MINDRAY MEDICAL INTERNATIONAL LIMITED: DEALS,
JANUARY 2021–NOVEMBER 2024 377
TABLE 443 ESAOTE SPA: COMPANY OVERVIEW 378
TABLE 444 ESAOTE SPA: PRODUCTS OFFERED 379
TABLE 445 ESAOTE SPA: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 381
TABLE 446 ESAOTE SPA: DEALS, JANUARY 2021–NOVEMBER 2024 381
TABLE 447 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 382
TABLE 448 CHISON MEDICAL TECHNOLOGIES CO., LTD.: PRODUCTS OFFERED 383
TABLE 449 CHISON MEDICAL TECHNOLOGIES CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 384
TABLE 450 CHISON MEDICAL TECHNOLOGIES CO., LTD.: DEALS, JANUARY 2021–NOVEMBER 2024 384
TABLE 451 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 385
TABLE 452 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 386
TABLE 453 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 387
TABLE 454 KONICA MINOLTA, INC.: COMPANY OVERVIEW 388
TABLE 455 KONICA MINOLTA, INC.: PRODUCTS OFFERED 389
TABLE 456 CLARIUS: COMPANY OVERVIEW 390
TABLE 457 CLARIUS: PRODUCTS OFFERED 390
TABLE 458 CLARIUS: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 391
TABLE 459 CLARIUS: DEALS, JANUARY 2021–NOVEMBER 2024 392
TABLE 460 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW 393
TABLE 461 MEDGYN PRODUCTS, INC.: PRODUCTS OFFERED 393
TABLE 462 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 394
TABLE 463 PROMED TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 394
TABLE 464 WHITE EAGLE SONIC TECHNOLOGIES, INC.: COMPANY OVERVIEW 396
TABLE 465 SHENZHEN RICSO TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 397
TABLE 466 YOUKEY MEDICAL: COMPANY OVERVIEW 398
TABLE 467 SIUI: COMPANY OVERVIEW 399
TABLE 468 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING:
COMPANY OVERVIEW 400
TABLE 469 BUTTERFLY NETWORK, INC.: COMPANY OVERVIEW 401
TABLE 470 ALPINION MEDICAL SYSTEMS: COMPANY OVERVIEW 402
TABLE 471 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 403
TABLE 472 SHENZHEN LANDWIND INDUSTRY CO., LTD.: COMPANY OVERVIEW 404
TABLE 473 ECHONOUS INC.: COMPANY OVERVIEW 405
TABLE 474 MOBISANTE, INC.: COMPANY OVERVIEW 406
TABLE 475 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 407
TABLE 476 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 408
TABLE 477 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW 408
TABLE 478 CURA HEALTHCARE: COMPANY OVERVIEW 410
LIST OF FIGURES
FIGURE 1 ULTRASOUND MARKET SEGMENTATION & REGIONAL SCOPE 33
FIGURE 2 ULTRASOUND MARKET: RESEARCH DATA 37
FIGURE 3 RESEARCH DESIGN 38
FIGURE 4 PRIMARY SOURCES 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 42
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 42
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 43
FIGURE 8 ULTRASOUND MARKET SIZE ESTIMATION: APPROACH 1
(COMPANY REVENUE ESTIMATION) 44
FIGURE 9 ULTRASOUND MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 45
FIGURE 10 TOP-DOWN APPROACH 46
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
FIGURE 12 DATA TRIANGULATION METHODOLOGY 48
FIGURE 13 ULTRASOUND MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION) 51
FIGURE 14 ULTRASOUND MARKET, BY DISPLAY, 2024 VS. 2030 (USD MILLION) 52
FIGURE 15 ULTRASOUND MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 53
FIGURE 16 ULTRASOUND MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 54
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF ULTRASOUND MARKET 55
FIGURE 18 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 56
FIGURE 19 EUROPE TO DOMINATE DURING FORECAST PERIOD 57
FIGURE 20 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 58
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 22 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60
FIGURE 23 ULTRASOUND MARKET: VALUE CHAIN ANALYSIS 70
FIGURE 24 ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 25 ULTRASOUND MARKET: PORTER’S FIVE FORCES 72
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 74
FIGURE 27 KEY BUYING CRITERIA, BY END USER 75
FIGURE 28 PATENT ANALYSIS FOR ULTRASOUND MARKET (JANUARY 2013–DECEMBER 2024) 76
FIGURE 29 ULTRASOUND MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85
FIGURE 31 INVESTMENT & FUNDING SCENARIO, 2018–2022 96
FIGURE 32 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 96
FIGURE 33 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION) 97
FIGURE 34 AVERAGE SELLING PRICE OF ULTRASOUND, BY REGION, 2021–2023 (USD) 99
FIGURE 35 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER (2023) 101
FIGURE 36 EUROPE: ULTRASOUND MARKET SNAPSHOT 215
FIGURE 37 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT 259
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN ULTRASOUND MARKET,
2021–2023 (USD BILLION) 316
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ULTRASOUND MARKET (2023) 317
FIGURE 40 TOP FIVE COMPANIES COLLECTIVELY ACCOUNT FOR 73–77% MARKET SHARE
OF GLOBAL DOPPLER ULTRASOUND MARKET 317
FIGURE 41 RANKING OF KEY PLAYERS IN ULTRASOUND MARKET, 2023 319
FIGURE 42 DIAGNOSTIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 320
FIGURE 43 ULTRASOUND MARKET: COMPANY FOOTPRINT 321
FIGURE 44 THERAPEUTIC ULTRASOUND MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 330
FIGURE 45 EV/EBITDA OF KEY VENDORS 332
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 332
FIGURE 47 ULTRASOUND MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 333
FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 337
FIGURE 49 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023) 344
FIGURE 50 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023) 349
FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 354
FIGURE 52 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023) 359
FIGURE 53 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 364
FIGURE 54 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023) 369
FIGURE 55 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023) 373
FIGURE 56 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT (2022) 386
FIGURE 57 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2023) 389
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11